Skip to content

Robotic Versus Open Ventral Hernia Repair

Robotic Versus Open Ventral Hernia Repair: A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05472987
Acronym
ROVHR
Enrollment
200
Registered
2022-07-25
Start date
2022-07-25
Completion date
2027-08-01
Last updated
2026-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventral Hernia

Keywords

Robotic, Hernia, Ventral hernia, Open hernia, Mesh

Brief summary

This is a randomized trial comparing open retromuscular ventral hernia repair to robotic retromuscular ventral hernia repair.

Detailed description

This is a randomized trial comparing open retromuscular ventral hernia repair to robotic retromuscular ventral hernia repair. This is a superiority trial with a primary outcome of length of stay in the hospital, theorizing that robotic retromuscular ventral hernia repairs are superior to open ventral hernia repairs by reducing length of stay by 24 hours. Patients will be blinded to the intervention, groups will be in parallel, and the primary outcome (when the patient is discharged) will be determined by a blinded assessor.

Interventions

PROCEDUREVentral Hernia Repair

Patients will undergo retromuscular ventral hernia repair

Sponsors

Lucas Beffa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Patients will be blinded to the intervention. The primary outcome will be determined by a surgeon other than the operating surgeon who is blinded to the intervention. Patients will also receive the same dressings over their wounds and an abdominal binder will be placed over the abdomen in attempts to limit the unblinding of the patient.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years and older * 7 cm to 15 cm wide hernia midline defects * BMI less than or equal to 45 * Patient deemed both an open and robotic candidate by operating surgeon

Exclusion criteria

* 17 years old or younger * prisoners * pregnant patients * Emergent patients * BMI greater than 45 * Hernia defects less than 7 cm or greater than 15 cm in width

Design outcomes

Primary

MeasureTime frameDescription
Length of Stay30 daysTime in the hospital after the surgery

Secondary

MeasureTime frameDescription
Post-operative wound complications30 day and one yearany abnormal wound healing
Other post operative complications30 daysHeart attacks, acute kidney injury, admissions to ICU, respiratory failure
Readmission rate30 daysReadmission to the hospital within 30 days of the surgery
Opioid consumption30 days and one yearOpioid prescribed and consumed
Acute pain scores5 days after surgeryNumeric Rating Scale-11 pain scores daily, 0-10 with 0 being no pain and 10 being the worst pain for first five days after surgery
Hernia Related Specific Quality of Life Score30 days and one yearScore of 0-100 with lower scores indicating worse quality of life
Direct cost30 daysCost to the hospital
Quality of life scores using European Hernia Society (EuraHS) scale30 day and one yearEuraHS is a hernia specific quality of life scale with three domains: pain, restrictions of activity, and cosmesis. 0-30 with higher scores indicating a worse quality of life.
Hernia recurrence30 days and one yearHernia recurrence

Countries

United States

Contacts

CONTACTLucas Beffa, MD
beffal@ccf.org216-445-5975
CONTACTRiley Wilkinson, MD
wilkinr3@ccf.org
PRINCIPAL_INVESTIGATORLucas Beffa, MD

The Cleveland Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 15, 2026